| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1365178 | Bioorganic & Medicinal Chemistry Letters | 2008 | 5 Pages |
Abstract
A series of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines were synthesized and evaluated for their antihyperglycemic activity. Compounds 3g and 6d exhibited lowering of postprandial plasma glucose by 30.7%, 23.3% in SLM and 25.6%, 25.4% in STZ models respectively which is significant compared to metformin and glybenclamide. Other compounds exhibited moderate to good activity ranging from 19.5% to 32.8% in SLM and 3.26% to 25.4% in STZ models.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Atma P. Dwivedi, Shailesh Kumar, Vandana Varshney, Amar B. Singh, Arvind K. Srivastava, Devi P. Sahu,